Peter McPartland

Peter McPartland is currently the Director at PharmEnable. Prior to this, they were with GKMH Limited, Cambridge Enterprise, nucleus.biomed, SV Life Sciences Advisers LLP, Schroder Venture Advisers, and Schroder Securities Ltd. Peter has over 30 years of experience in the financial sector, with a focus on life sciences and venture capital.

Peter McPartland has a long and successful history in the financial sector. Peter started their career in 1982 as a Senior Investment Analyst at Panmure Gordon & Co. Peter then moved to Schroder Securities Ltd in 1984, where they served as Director of Research. In 1988, they joined Schroder Venture Advisers as an Executive and Principal.

In 1994, they co-founded SV Life Sciences Advisers LLP, where they served as a General Partner and Venture Partner for 13 years. During their time at SV Life Sciences Advisers LLP, they helped many life science companies grow and succeed. In 2007, they left SV Life Sciences Advisers LLP to join Cambridge Enterprise as an Entrepreneur In Residence - Life Sciences.

At Cambridge Enterprise, Peter McPartland helped many early-stage companies get off the ground. In 2018, they left Cambridge Enterprise to join GKMH Limited as a Director. Peter is currently with PharmEnable, where they are helping the company develop and commercialize new drugs and therapies.

Peter McPartland has a BSc in Pharmacology from UCL and an MSc in Science Studies from The Open University.